Drug profile · INN
crinecerfont
CRENESSITY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
crinecerfont (CRENESSITY) is an FDA-listed pharmaceutical active ingredient. Associated with NEUROCRINE BIOSCIENCES INC. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN crinecerfont
Brand CRENESSITY
Route ORAL
Formulation CAPSULE
Originator NEUROCRINE BIOSCIENCES INC
Frequently asked questions
What is crinecerfont?
crinecerfont (CRENESSITY) is an FDA-listed pharmaceutical active ingredient. Associated with NEUROCRINE BIOSCIENCES INC. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for crinecerfont?
CRENESSITY is a marketed brand name for crinecerfont. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of crinecerfont?
crinecerfont has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.